✅ Active Ingredient Overview Table:
| 🔬 Active Ingredient (Generic Name): | Varenicline Tartrate |
|---|---|
| 💊 Indication: | Smoking Cessation (Tobacco Dependence) |
| 🇺🇸 US Brand: | Chantix |
| 🏭 Manufacturer: | Healing Pharma (Founded: 2010) |
| 📦 Packaging: | 10 Tablets per Box |
| 🧪 Strength: | 1 mg |
| 🚚 Delivery Time: | 6–15 days |
🌿 What is Varenicline 1 mg (Varenismart)?
Varenismart 1 mg represents the maintenance dose of Varenicline Tartrate, a targeted partial agonist at α4β2 nicotinic acetylcholine receptors in the brain. After a careful titration period, patients transition to this 1 mg twice-daily regimen to sustain receptor occupancy, significantly reducing nicotine cravings and blocking the reinforcing effects of smoking.
Quitting tobacco is a major challenge, with withdrawal symptoms such as irritability, anxiety, and cognitive fog affecting up to 90% of quitters. Varenicline’s dual action not only mitigates these withdrawal symptoms but also diminishes the pleasurable feedback loop triggered by nicotine. Clinical trials reveal that maintaining a 1 mg dose twice daily doubles the abstinence rates at 12 weeks compared to placebo, with prolonged abstinence extending benefits through 52 weeks in many users.
Moreover, real-world data suggest that combining Varenismart 1 mg with supportive behavioral interventions yields the highest long-term quit rates. Patients also report improved mood and concentration, demonstrating Varenicline’s positive impact on both physiological dependence and psychological withdrawal.
🧬 Pharmacology & Mechanism of Action
| Attribute | Detail |
|---|---|
| Chemical Formula | C13H13N3O2•2HCl |
| Molecular Weight | 261.7 g/mol (tartrate salt) |
| Bioavailability | ~90% |
| Metabolism | Minimal hepatic (renal excretion) |
| Half-Life | ~24 hours |
By partially activating and simultaneously blocking nicotinic receptors, Varenicline reduces withdrawal and prevents nicotine’s rewarding effects.
💡 Indications & Dosing
| Phase | Dose & Administration |
|---|---|
| Maintenance (Weeks 2–12) | 1 mg twice daily, after titration with 0.5 mg dose |
Begin 0.5 mg once daily on days 1–3, then 0.5 mg twice daily on days 4–7, transitioning to 1 mg twice daily on day 8. Continue for 11 more weeks for optimal results.
⚠️ Warnings & Side Effects
Common:
- Nausea, vivid dreams
- Insomnia, headache
Serious:
- Neuropsychiatric events (mood changes, suicidal ideation)
- Cardiovascular events in at-risk populations
Encourage patients to monitor mood and report any behavioral changes. Use caution in those with cardiovascular disease and avoid alcohol which may exacerbate neuropsychiatric effects.
🏥 Storage Instructions
Store Varenismart 1 mg in its original carton at 20–25°C. Keep away from moisture and direct sunlight. Store out of reach of children.
🌐 Availability & Purchasing
- USA: Prescription-only (Chantix); brand and generic available.
- UK & EU: Prescription required; varenicline generics.
- Australia: Prescription and TGA approval required.
International sourcing can lower costs; ensure you comply with local regulations and maintain a valid prescription.
🔗 Related Smoking Cessation Therapies
- Varenismart 0.5 mg – initial titration dose.
- Zyban (Bupropion SR) 150 mg – non-nicotine adjunct.
- Nicotine Gum 4 mg – oromucosal quitting aid.
🎥 Educational Video on Varenicline Maintenance Therapy
👩⚕️ Expert Insight: Dr. Sunita Rao, Addiction Specialist
“Transitioning to Varenicline 1 mg twice daily is critical for sustaining receptor engagement and maximizing quit rates. Combined with counseling, Varenismart significantly improves long-term abstinence.”

